Compass Therapeutics Stock (NASDAQ: CMPX) stock price, news, charts, stock research, profile.
Open | $1.08 |
Close | $1.08 |
Volume / Avg. | 640.44K / 334.61K |
Day Range | 1.00 - 1.10 |
52 Wk Range | 0.77 - 3.01 |
Market Cap | $141.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 2.08% |
Days to Cover | 5.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.
Other companies in Compass Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), FibroGen (NASDAQ:FGEN) and Adicet Bio (NASDAQ:ACET).
There is no analysis for Compass Therapeutics.
Compass Therapeutics has a consensus price target of $9.75.
The stock price for Compass Therapeutics (NASDAQ: CMPX) is $1.03 last updated July 26, 2024 at 7:37 AM EDT.
There are no upcoming dividends for Compass Therapeutics.
Compass Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Compass Therapeutics.
Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.